Table 2.
All subjects (N=84) | Cherry extract (n=41) | Diet modification (n=43) | |
---|---|---|---|
| |||
Physician office communication | |||
Gout diagnosis confirmation | 100% | 100% | 100% |
ACR gout classification criteria | 94% | 93% | 95% |
Internet study visits with survey assessments | |||
Baseline assessment | 100% | 100% | 100% |
3-month assessment | 93% | 100% | 86% |
6-month assessment | 81% | 90% | 72% |
9-month assessment | 69% | 78% | 60% |
Serum urate blood draw testing1 | |||
Baseline | 100% | 100% | 100% |
9-month | 77% | 83% | 72% |
2-weekly Gout flare assessment2 | 75% | 82% | 69% |
Telephone support sessions for diet modification (Dietitian) | |||
Baseline | -- | -- | 83% |
6-month | -- | -- | 87% |
9-month | -- | -- | 86% |
Telephone support sessions for cherry extract adherence (study coordinator) | |||
Baseline | -- | 97% | -- |
1-month | -- | 90% | -- |
4-month | -- | 81% | -- |
All study procedures and visits were completed over the Internet by participants in the comfort of their homes, or on the phone
Serum urate blood draw was done at the Quest Laboratory site closest to the patient residence or by patient choice, and results were reported directly to the study team in a HIPAA-compliant method
Two- weekly Gout flare assessments were done via the Internet; non-responders received a follow-up phone call to complete the brief questionnaire on the phone lasting <2 minutes